The adjuvanted RSV prefusion F protein-based vaccine RSVPreF3-AS01E Arexvy was first FDA approved for older adults in May ...

Common and highly contagious illnesses are reaching several-month highs. Norovirus has almost reached a several-year record.

RSV is "a common respiratory virus that infects the nose, throat, and lungs. RSV symptoms make it difficult to distinguish it ...

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity -; primarily organ transplant recipients who take immunosuppressive medications to reduce the risk of ...

Covid-19 and respiratory syncytial virus (RSV). These requirements replace the previous reporting standards and include data on facility census, resident vaccination status for COVID-19, influenza, ...

The study followed 38 immunocompromised adults, aged 64 to 72, who received either the Arexvy or Abrysvo RSV vaccine. Researchers found that people aged 60 and older who are immunocompromised ...

Researchers have shown that people 60 years or older with weakened immunity do not respond as strongly to vaccines against the respiratory syncytial virus (RSV) as people in the same age group with ...

Feeling ill after that Christmas or New Year's Eve party? If could be RSV. But how can you know for sure? Here are the ...

Credit: Getty Images / Nenov US-based clinical-stage intranasal vaccine company, Blue Lake Biotechnology’s pediatric nasal vaccine for respiratory syncytial virus (RSV), BLB201, was safe and effective ...

While the functions of G-quadruplexes in orthoflavivirus genomes remain unknown, the genus-wide conservation of genomic sequences that can form these structures suggests ... not able to be determined.

A biosecurity breach has come to light in Queensland, Australia, where 323 vials containing live viruses, including Hendra virus, Lyssavirus, and Hantavirus, have gone missing. The breach ...